阅读说明
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
分类依据与纠错
分类依据题名和摘要中的方法词与领域语境,不使用期刊名称猜测研究方向。
正在核对关联版本…
代码、数据与补充材料
正在核对对应版本的资源…
关注这篇论文的作者
原文摘要
Quantifying heritability is the first step in understanding the contribution of genetic variation to the risk architecture of complex human diseases and traits. Heritability can be estimated for univariate phenotypes from nonfamily data using linear mixed effects models. There is, however, no fully developed methodology for defining or estimating heritability from longitudinal studies. By examining longitudinal studies, researchers have the opportunity to better understand the genetic influence on the temporal development of diseases, which can be vital for populations with rapidly changing phenotypes such as children or the elderly. To define and estimate heritability for longitudinally measured phenotypes, we present a framework based on functional data analysis, FDA. While our procedures have important genetic consequences, they also represent a substantial development for FDA. In particular, we present a very general methodology for constructing optimal, unbiased estimates of variance components in functional linear models. Such a problem is challenging as likelihoods and densities do not readily generalize to infinite-dimensional settings. Our procedure can be viewed as a functional generalization of the minimum norm quadratic unbiased estimation procedure, MINQUE, presented by C. R. Rao, and is equivalent to residual maximum likelihood, REML, in univariate settings. We apply our methodology to the Childhood Asthma Management Program, CAMP, a 4-year longitudinal study examining the long term effects of daily asthma medications on children.